Oncogenic activation of androgen receptor

Neuroscience

• Androgen Receptor 100%
• Androgen 53%
• Neuropeptide 26%
• Bombesin 26%
• Gastrin-Releasing Peptide 20%
• Cell Line 13%
• Receptor Tyrosine Kinase 13%
• Tyrosine Kinase 13%
• In Vivo 6%
• In Vitro 6%
• Response Element 6%
• Prostate 6%
• Tyrosine Kinase Inhibitor 6%
• cDNA Microarray 6%
• Oncogene C Myc 6%
• Autocrine Effect 6%
• Immunoprecipitation 6%
• Adjuvant Therapy 6%
• Epileptic Absence 6%
• Transactivation 6%
• Transgene 6%
• G Protein Coupled Receptor 6%

Biochemistry, Genetics and Molecular Biology

• Androgen Receptor 100%
• LNCaP 26%
• Bombesin 26%
• Neuropeptide 26%
• Gastrin-Releasing Peptide 20%
• Tyrosine Kinase 13%
• Receptor Tyrosine Kinase 13%
• Cancer Cell 6%
• Response Element 6%
• cDNA Microarray 6%
• Oncogene C Myc 6%
• Transactivation 6%
• Chromatin Immunoprecipitation 6%
• Tyrosine Kinase Inhibitor 6%
• Transgene 6%
• Autocrine Effect 6%
• Hope 6%
• G Protein Coupled Receptor 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Androgen Receptor 100%
• Androgen 53%
• Neuropeptide 26%
• Bombesin 26%
• Gastrin Releasing Peptide 20%
• Protein Tyrosine Kinase 13%
• Absence 6%
• Prostate Cancer 6%
• Protein Tyrosine Kinase Inhibitor 6%
• Chromatin Immunoprecipitation 6%
• Castration Resistant Prostate Cancer 6%
• Complementary DNA 6%
• G Protein Coupled Receptor 6%